Research Roundup

Debbie Rigby presents the latest research news relevant to pharmacists Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillationA sub-hoc analysis of the ARISTOTLE trial has shown three-quarters of patients had polypharmacy; and this subgroup had an increased comorbidity, more interacting drugs, increased mortality, and higher rates of thromboembolic and bleeding complications.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Labor leads in health policy scorecards
Next How pharmacists manage under pressure: study